Northern Trust’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$16.8M Buy
1,201,709
+69,536
+6% +$973K ﹤0.01% 1753
2025
Q1
$15.4M Sell
1,132,173
-69,345
-6% -$943K ﹤0.01% 1786
2024
Q4
$24.5M Buy
1,201,518
+115,876
+11% +$2.36M ﹤0.01% 1570
2024
Q3
$31.6M Buy
1,085,642
+2,683
+0.2% +$78.2K 0.01% 1331
2024
Q2
$25.1M Sell
1,082,959
-5,554
-0.5% -$129K ﹤0.01% 1414
2024
Q1
$22.3M Sell
1,088,513
-13,166
-1% -$270K ﹤0.01% 1516
2023
Q4
$23.6M Sell
1,101,679
-15,063
-1% -$323K ﹤0.01% 1495
2023
Q3
$23M Buy
1,116,742
+27,044
+2% +$558K ﹤0.01% 1449
2023
Q2
$32.2M Buy
1,089,698
+71,694
+7% +$2.12M 0.01% 1258
2023
Q1
$23.5M Buy
1,018,004
+33,813
+3% +$779K ﹤0.01% 1455
2022
Q4
$27.4M Buy
984,191
+94,223
+11% +$2.62M 0.01% 1332
2022
Q3
$27.3M Sell
889,968
-650
-0.1% -$19.9K 0.01% 1254
2022
Q2
$26.2M Sell
890,618
-15,610
-2% -$459K 0.01% 1351
2022
Q1
$29.2M Sell
906,228
-52,861
-6% -$1.7M 0.01% 1407
2021
Q4
$42.8M Buy
959,089
+7,364
+0.8% +$328K 0.01% 1220
2021
Q3
$48M Sell
951,725
-27,333
-3% -$1.38M 0.01% 1104
2021
Q2
$76.8M Buy
979,058
+225,424
+30% +$17.7M 0.01% 819
2021
Q1
$43M Sell
753,634
-24,111
-3% -$1.38M 0.01% 1236
2020
Q4
$65.1M Sell
777,745
-11,273
-1% -$944K 0.01% 888
2020
Q3
$28.3M Sell
789,018
-43,242
-5% -$1.55M 0.01% 1347
2020
Q2
$20.1M Buy
832,260
+134,061
+19% +$3.24M ﹤0.01% 1618
2020
Q1
$12.2M Buy
698,199
+63,187
+10% +$1.11M ﹤0.01% 1749
2019
Q4
$11.1M Sell
635,012
-19,439
-3% -$339K ﹤0.01% 2113
2019
Q3
$10M Buy
654,451
+34,401
+6% +$527K ﹤0.01% 2138
2019
Q2
$12.9M Buy
620,050
+6,063
+1% +$126K ﹤0.01% 1988
2019
Q1
$14.3M Buy
613,987
+23
+0% +$534 ﹤0.01% 1914
2018
Q4
$12.7M Buy
613,964
+14,105
+2% +$291K ﹤0.01% 1910
2018
Q3
$13M Buy
599,859
+412,925
+221% +$8.98M ﹤0.01% 2090
2018
Q2
$2.85M Buy
186,934
+18,885
+11% +$288K ﹤0.01% 3009
2018
Q1
$3.31M Buy
+168,049
New +$3.31M ﹤0.01% 2829